John Green on the difficult campaign to eradicate a deadly disease. ‘Funding for TB is in crisis,’ says John Green, author of ...

Rifampicin is the key drug used for the first-line treatment of tuberculosis (TB). Treatment of TB is a key national health priority as it has been endemic in India, contagious and causes a large ...

Tuberculosis is the leading infectious cause of death around the world, outpaced only by COVID-19 during the first three ...

India accounts for 30% of the global TB burden and 62% of multidrug-resistant cases. Despite a 17.7% reduction in incidence since 2015, achieving the 2025 target remains daunting. Experts advocate for ...

So for an inexperienced doctor, TB may not be the first diagnosis. EPTB is a challenge for ... whether it is a routine TB ...

New Delhi [India], March 17 (ANI): The drug Rifampicin, which is used in serious bacterial infections, particularly Tuberculosis, is expected to be commissioned this year. According to the ...

In 2023, after a brief hiatus, tuberculosis regained from COVID its status as the world’s deadliest infectious disease—a ...

Cases of tuberculosis (TB), the world’s deadliest infectious disease, are up nearly 10 per cent year-over-year among children ...

For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately ... income settings. Second-line DST is more difficult than first-line DST, but promising ...

An outbreak of tuberculosis (TB), a lung disease often marked by a persistent cough, began in January 2024 in Kansas City, ...

She said that Ukraine had ordered a shipment of 3 months’ worth of first-line TB medications in October 2024 that will no longer be delivered due to the cessation of USAID operations.

Tuberculosis surveillance and monitoring report, released today by the European Centre for Disease Prevention and Control ...